Mental Health Clinics in Upper Arlington, OH Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Park-saltzman Psychological Services, Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4929 Dierker Rd Ste A, Upper Arlington, OH 43220 Phone: 614-929-5170 Fax: 614-929-5180 |
Jones Neurology Ltd Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 1699 W Lane Ave, Upper Arlington, OH 43221 Phone: 614-487-1409 |
Kristina L Edler, Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3040 Riverside Dr Ste 206, Upper Arlington, OH 43221 Phone: 614-209-1234 |
J. Eric Gentile Ms Lpcc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 4861 Nugent Dr, Upper Arlington, OH 43220 Phone: 614-940-9834 |
News Archive
Bar-codes for babies
Hospital Corporation of America, the nation's largest hospital system, is testing new procedures to place bar-coded tags on babies' ankles to ensure they receive the proper medical care and ensure that the right baby goes home with the right family.
New feature on SciVerse ScienceDirect presents proteins in three dimensions
Elsevier, a world-leading publisher of scientific, medical and technical products and services, introduces Protein Viewer, a new, interactive feature on SciVerse ScienceDirect for the Journal of Molecular Biology (JMB). With Protein Viewer, readers of JMB now have the power to expand and rotate molecules within the actual article. SciVerse ScienceDirect merges features of the World Protein Database and Jmol, and embeds them into the article, making its use more convenient and user-friendly.
Targacept presents data from Phase 2b clinical trial of TC-5214
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics-, today announced the presentation of data from its recently completed Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment in subjects with major depressive disorder, or MDD, who did not respond adequately to first-line treatment with the representative SSRI citalopram hydrobromide.
Sanofi terminates option and license agreement for Ardelyx's portfolio of NaP2b inhibitors
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced that Sanofi notified Ardelyx of its termination of the option and license agreement for Ardelyx's portfolio of NaP2b inhibitors effective September 30, 2015.
Romney's clues on pre-existing conditions, lack of health coverage
During a meeting with the Columbus Dispatch, GOP presidential hopeful Mitt Romney offered a comment about people who lack insurance which is being characterized by some news outlets as "controversial." Romney plans to repeal the health law but says uninsured people could still visit an emergency room and that people with preexisting conditions could keep their insurance. On this point, however, he has yet to provide specifics, news outlets report.
› Verified 6 days ago